UK Regulator Calls For More Patient Involvement In Trial Design
More Flexible Rules On GCP And IMPs Are Planned
UK plans for a flexible and streamlined clinical trial regulatory regime are now out for consultation, covering areas such as investigational medicinal products, greater patient involvement in trial design, and lighter-touch oversight of low-intervention trials.